Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy

Int Immunopharmacol
11 May 2021
https://pubmed.ncbi.nlm.nih.gov/33989971/

Breast and Colon Cancer by Dr Yusuf Saleeby 2021 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Yusuf Saleeby: General Preventive and Integrative Medicine/ Restorative Medicine / Functional Medicine, presents on Breast and Colon Cancer.

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888

Nutrichem's LDN Book Event with Dr Adrienne Junek (Low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Adrienne Junek, MD, CCFP, ABOIM

Low-dose Naltrexone (LDN) & Chronic Pain

Nutrichem's LDN Book Events with Linda Elsegood (Low dose naltrexone) from LDN Research Trust on Vimeo.

The LDN Book Volume 2 & The Goals of the LDN Research Trust

Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway

Transl Oncol
01 February 2021
https://pubmed.ncbi.nlm.nih.gov/33540155/

Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients

MSN News Science Alert
11 February 2021
https://www.msn.com/en-us/news/technology/scientists-think-theyve-figured-out-whats-triggering-brain-fog-in-covid-19-patients/ar-BB1dBTTF?li=BBnbfcL

Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients

Cancer Cell
16 January 2021
https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00051-9

The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice

Gynecol Oncol
30 April 2011
https://pubmed.ncbi.nlm.nih.gov/21531450/

Low-dose naltrexone: tricking the body to heal itself

Exp Biol Med (Maywood)
September 2011
https://www.sciencedaily.com/releases/2011/09/110902133047.htm